Streetbeat News

RHNMF

Rhinomed Limited

Industry

Medicinal and Botanical Manufacturing

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 1, 2024, with notable gainers including EVIO, Australis Capital, and OrganiGram Holdings, among others. EVIO led with a 9900.00% increase. On the downside, Rhinomed, Khiron Life Sciences, and Item 9 Labs were among the top losers. This reflects a volatile day in the cannabis sector, impacting several US-listed companies such as OrganiGram Holdings (OGI), Psychemedics (PMD), Cronos Group (CRON), Tilray Brands (TLRY), Canopy Growth (CGC), Eastside Distilling (EAST), 22nd Century Group (XXII), Greenlane Holdings (GNLN), SNDL Inc. (SNDL), and Aurora Cannabis (ACB).

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:30 pm

Marijuana stocks experienced significant movements on December 20, 2023. Canopy Growth (CGC) saw an extraordinary rise of 827.46%, while EVIO plummeted by 99%. Other notable gainers include MJ Holdings (MJNE) and Greenlane Holdings (GNLN), with increases of 46.97% and 11.65% respectively. Conversely, MPX International (MPXOF) and Cann Gr (CNGGF) faced sharp declines. The volatility in the sector is evident, with several companies experiencing double-digit percentage changes in their stock prices.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:30 pm

The article reports on significant price movements in cannabis-related stocks on December 18, 2023. It lists the day's gainers and losers, with MPX International leading the gainers with a 2450.00% increase, and Cara Therapeutics experiencing the largest decline, down 47.98%. Notably, the article includes US-listed companies such as Greenlane Holdings, Urban-gro, cbdMD, Village Farms International, Corbus Pharmaceuticals, Cara Therapeutics, Canopy Growth, Neptune Wellness Solutions, Psychemedics, Mexco Energy, SNDL, and Tilray Brands.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 9:30 pm

On December 13, 2023, several cannabis-related stocks experienced significant price movements. Notable gainers included GrowLife, Cann Gr, and 1933 Industries, with GrowLife leading the pack with a 378.57% increase. Major US-listed companies that saw gains were GrowGeneration, Tilray Brands, Innovative Industrial Properties, Scotts Miracle-Gro, Corbus Pharmaceuticals, and SNDL. Conversely, notable losers included AusCann Group Holdings, Rhinomed, and CLS Holdings USA, with AusCann Group Holdings dropping by 46.67%. Canopy Growth, cbdMD, Genetic Technologies, and Mexco Energy were among the US-listed companies that faced declines.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.